Good medicine, bad medicine
Written by Howard Lovy
Published May 08, 2004
Published May 08, 2004
Robert Bradbury has some good news and some bad news about the National Institutes of Health nanomedicine roadmap initiative shindig this week:
- The good news... The NIH really seems to understand that to make progress in nanotech one must integrate researchers from various areas of expertise. The bad news... Few if any people attending the conference have read any of the background literature on what nanotechnology or nanomedicine really involve. When I mentioned or or , during the interactive periods they generally were unrecognized. This seems to be consistent with the Drexler v. Smalley debate which suggests that most scientists simply have not done their homework (in terms of learning about nanotechnology). More here
Related Posts
Nanobots: Body and antibody
Do no harm: Don't forget Freitas
For greener planet, remove people; results may vary
Keep reading for information and comments on this article, and add some feedback of your own!
- Good medicine, bad medicine
- Published: May 08, 2004
- Type:
- Section: Culture
- Writer: Howard Lovy
- Howard Lovy's BC Writer page
- Howard Lovy's personal site
- Spread the Word
- Like this article?
- Email this
Save to del.icio.us
Comments
Add your comment, speak your mind
(Or ping: http://blogcritics.org/mt/tb/15482)Personal attacks are not allowed. Please read our comment policy.




